Stay updated on ICT-107 Immunotherapy in GBM Clinical Trial

Sign up to get notified when there's something new on the ICT-107 Immunotherapy in GBM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ICT-107 Immunotherapy in GBM Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision metadata updated from v3.2.0 to v3.3.2 at the bottom of the page.
    Difference
    0.0%
    Check dated 2025-11-25T10:29:01.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The page now omits the notice about government funding and NIH operating status. All study details, eligibility criteria, and contacts remain unchanged.
    Difference
    0.3%
    Check dated 2025-11-18T06:49:01.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    No significant additions or deletions were observed between the old and new screenshots; core study details appear unchanged.
    Difference
    0.3%
    Check dated 2025-11-03T20:40:29.000Z thumbnail image
  5. Check
    59 days ago
    Change Detected
    Summary
    Major change: page now carries a government-operating-status notice and a new version tag (v3.2.0) replacing the old one (v3.1.0).
    Difference
    4%
    Check dated 2025-10-06T05:07:45.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    Update reflects a new software/version release (from v3.0.2 to v3.1.0).
    Difference
    0.1%
    Check dated 2025-09-29T02:59:27.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.
    Difference
    0.2%
    Check dated 2025-09-14T18:55:25.000Z thumbnail image

Stay in the know with updates to ICT-107 Immunotherapy in GBM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ICT-107 Immunotherapy in GBM Clinical Trial page.